Eva Sahakian

A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers

Krithika N. Kodumudi, Karrune Woan, Danielle L. Gilvary et al. · Clinical Cancer Research · 2010 · 495 citations · Full text

Essential role of HDAC6 in the regulation of PD‐L1 in melanoma

Maritza Lienlaf, Patricio Perez-Villarroel, Tessa Knox et al. · Molecular Oncology · 2016 · 164 citations · Full text

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

Tessa Knox, Eva Sahakian, Debarati Banik et al. · Scientific Reports · 2019 · 158 citations · Full text

Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75

Melanie Mediavilla-Varela, Fabio J. Pacheco, Frankis Almaguel et al. · Molecular Cancer · 2009 · 134 citations · Full text

Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation

Karrune Woan, Maritza Lienlaf, P. Perez-Villaroel et al. · Molecular Oncology · 2015 · 134 citations · Full text